BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 209379)

  • 1. Immunotherapy with tumor cells and BCG in the guinea pig, studied by immunological in vivo and in vitro experiments.
    Rella W; Chaput B
    Oncology; 1978; 35(3):136-42. PubMed ID: 209379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of complement-dependent antibody to tumor cells in sera of strain-2 guinea pigs cured of their tumors by BCG Treatment.
    Boyle MD; Ohanian SH; Borsos T
    J Natl Cancer Inst; 1976 Mar; 56(3):623-6. PubMed ID: 176400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of in vitro cell-mediated reactivity against syngeneic tumor cells by various lymphoid cell populations from Bacillus Calmette-Guérin-tumor-cured, tumor-sensitized, tumor-bearing, and normal inbred guinea pigs.
    Fidler IJ; Kataoka T; Hanna MG
    Cancer Res; 1976 Dec; 36(12):4459-66. PubMed ID: 187324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple in vitro mechanisms of tumor cytotoxicity demonstrated in the line-1 guinea pig hepatoma model.
    Osteen RT; Piessens WF; David JR; Churchill WH
    J Natl Cancer Inst; 1975 Oct; 55(4):873-8. PubMed ID: 52720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histopathology of tumor regression after intralesional injection of Mycobacterium bovis. IV. Development of immunity to tumor cells and BCG.
    Hanna MG; Snodgrass MJ; Zbar B; Rapp HJ
    J Natl Cancer Inst; 1973 Dec; 51(6):1897-908. PubMed ID: 4358147
    [No Abstract]   [Full Text] [Related]  

  • 6. Antitumor activity of bacterial infection. II. effect of Listeria monocytogenes on growth of a guinea pig hepatoma.
    Bast RC; Zbar B; Miller TE; Mackaness GB; Rapp HJ
    J Natl Cancer Inst; 1975 Mar; 54(3):757-61. PubMed ID: 164568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of tumor growth in strain 2 guinea pigs by xenogeneic antitumor antibody.
    Smith HG; Meltzer MS; Leonard EJ
    J Natl Cancer Inst; 1976 Oct; 57(4):809-13. PubMed ID: 187778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression and regression of a transplanted tumor in the guinea pig colon mediated by Mycobacterium bovis, strain BCG.
    Harmel RP; Zbar B; Rapp HJ
    J Natl Cancer Inst; 1975 Feb; 54(2):515-7. PubMed ID: 234537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Responses of tumors induced in inbred guinea pig strain JY=1 and strain Hartley/F to BCG.
    Kataoka T; Tokunaga T; Murohashi T
    J Natl Cancer Inst; 1977 Mar; 58(3):803-8. PubMed ID: 320348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histopathology of Mycobacterium bovis (BCG)-mediated tumor regression.
    Hanna MG; Snodgrass MJ; Zbar B; Rapp HJ
    Natl Cancer Inst Monogr; 1972 Dec; 35():345-58. PubMed ID: 4349152
    [No Abstract]   [Full Text] [Related]  

  • 11. Resistance of guinea-pig hepatoma cells to complement-mediated lysis induced by ascites fluid or serum from tumor-bearing animals.
    Abe S; Berczi I; Sehon AH
    Int J Cancer; 1977 Oct; 20(4):595-606. PubMed ID: 199549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete regression of a guinea pig hepatocarcinoma by immunotherapy with "tumor-immune" RNA or antibody to fibrin fragment E.
    Schlager SI; Dray S
    Isr J Med Sci; 1976; 12(4-5):344-59. PubMed ID: 181352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of BCG on cell-mediated cytotoxicity and serum blocking factor during growth of rat hepatoma.
    Embleton MJ
    Br J Cancer; 1976 Jun; 33(6):584-92. PubMed ID: 181041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy of guinea pig cancer with BCG.
    Zbar B
    Johns Hopkins Med J Suppl; 1974; 3():121-30. PubMed ID: 4608693
    [No Abstract]   [Full Text] [Related]  

  • 15. Destruction of syngeneic tumors by tuberculin-stimulated peritoneal exudate cells from guinea pigs immunized to Mycobacterium bovis (strain BCG).
    Zwilling BS; Leonard EJ; Bast RC; Zbar B
    J Natl Cancer Inst; 1974 Aug; 53(2):541-6. PubMed ID: 4367248
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of antibody-complement-mediated killing of tumor cells by hormones.
    Schlager SI; Ohanian SH; Borsos T
    Cancer Res; 1976 Oct; 36(10):3672-7. PubMed ID: 182362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of anti-tumour immunity in guinea-pigs by methanol extraction residue of BCG.
    Wainberg MA; Deutsch V; Weiss DW
    Br J Cancer; 1976 Nov; 34(5):500-8. PubMed ID: 187207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histologic and ultrastructural studies of tumor regression in inbred guinea pigs after intralesional injection of Mycobacterium bovis (BCG).
    Hanna MG; Snodgrass MJ; Zbar B; Rapp HJ
    Natl Cancer Inst Monogr; 1973 Dec; 39():71-85. PubMed ID: 4362524
    [No Abstract]   [Full Text] [Related]  

  • 19. Morphological evidence for the translocation of lysosomal organelles from cytotoxic macrophages into the cytoplasm of tumor target cells.
    Bucana C; Hoyer LC; Hobbs B; Breesman S; McDaniel M; Hanna MG
    Cancer Res; 1976 Dec; 36(12):4444-58. PubMed ID: 187323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy of established micrometastases with Bacillus Calmette-Guérin tumor cell vaccine.
    Hanna MG; Peters LC
    Cancer Res; 1978 Jan; 38(1):204-9. PubMed ID: 201374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.